0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antipyretic Chinese Traditional Medicine Market Research Report 2026
Published Date: 2026-01-22
|
Report Code: QYRE-Auto-28A5719
Home | Market Reports | Health| Nursing
Global and United States Antipyretic Chinese Traditional Medicine Market Report Forecast 2022 2028
BUY CHAPTERS

Global Antipyretic Chinese Traditional Medicine Market Research Report 2026

Code: QYRE-Auto-28A5719
Report
2026-01-22
Pages:173
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Antipyretic Chinese Traditional Medicine Market Size

The global Antipyretic Chinese Traditional Medicine market was valued at US$ 3259 million in 2025 and is anticipated to reach US$ 5172 million by 2032, at a CAGR of 6.8% from 2026 to 2032.

Antipyretic Chinese Traditional Medicine Market

Antipyretic Chinese Traditional Medicine Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Antipyretic Chinese Traditional Medicine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
In 2025, global Antipyretic Chinese Traditional Medicine reached approximately 366.2 M Units, with an average global market price of around 8.9 USD/unit.
ntipyretic Chinese Traditional Medicine refers to a category of traditional Chinese medicinal materials and preparations guided by traditional Chinese medicine theory, which are mostly cold in nature and bitter in taste, and mainly function to clear away internal heat, reduce fever and detoxify through ingredients such as flavonoids and alkaloids. It is used to treat various fever symptoms caused by exogenous pathogens, internal heat accumulation or yin deficiency, and can be divided into types such as clearing heat and purging fire, clearing heat and detoxifying, and clearing heat and cooling blood. Common varieties include honeysuckle, chrysanthemum, coptis, and preparations such as Yin Qiao San and Huang Lian Jie Du Tang.
Driven by the policy of traditional Chinese medicine revitalization, the increase in self-medication awareness, and the preference for mild and safe antipyretic products, the demand for antipyretic traditional Chinese medicine shows a steady growth trend. The market scale is expanding year by year, with the OTC channel and online sales channel growing rapidly, and there is a large demand for products for special groups such as children and the elderly. Business opportunities lie in the development of new preparations with high efficiency and convenient administration, the strengthening of quality control and evidence-based medical research, the expansion of international markets, and the development of personalized products and health management services to meet diversified market needs.
This report delivers a comprehensive overview of the global Antipyretic Chinese Traditional Medicine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Antipyretic Chinese Traditional Medicine. The Antipyretic Chinese Traditional Medicine market size, estimates, and forecasts are provided in terms of sales volume (M Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Antipyretic Chinese Traditional Medicine market comprehensively. Regional market sizes by Dosage Form, by Sales Channel, by Product Attribute, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Antipyretic Chinese Traditional Medicine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Dosage Form, by Sales Channel, and by region.
Market Segmentation

Scope of Antipyretic Chinese Traditional Medicine Market Report

Report Metric Details
Report Name Antipyretic Chinese Traditional Medicine Market
Accounted market size in 2025 US$ 3259 million
Forecasted market size in 2032 US$ 5172 million
CAGR 6.8%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Dosage Form
  • Granule
  • Capsule
  • Tablet
  • Oral Liquid
  • Injection
Segment by Product Attribute
  • OTC Patent Medicine
  • Prescription Patent Medicine
Segment by Therapeutic Function
  • Heat-Clearing and Detoxifying
  • Wind-Heat Releasing
  • Exterior-Releasing and Antipyretic
  • Damp-Heat Clearing
  • Qi and Yin Supporting With Heat Relief
  • by Sales Channel
  • Online Sales
  • Offline Sales
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Langrun, Hubei Jumpcan Pharmaceutical, Chasesun Pharmaceutical, Yangtze River Pharmaceutical, Jiangsu Kanion Pharmaceutical, Guangdong Leiyunshang, Shineway Pharma, Qingfeng Pharmaceutical, Jiangxi Prozin Pharmaceutical, Zhenao Jinyinhua Pharmaceutical, Shandong Runzhong Pharmaceutical, Sinopharm Group, Baiyunshan Mingxing Pharmaceutical, Guangzhou Pharmaceuticals Corporation, Yunnan Baiyao, CR Pharmaceutical Commercial Group, JiLin FuKang Pharmaceutical, Zhejiang CONBA Pharmaceutical, SemBioSys Genetics, Wecome Pharmaceutica, Guizhou Bailing Group Pharmaceutica, Xiuzheng Pharmaceutical, Taiji, China Beijing Tong Ren Tang Group Co. Ltd., Kunming Pharma, CR Sanjiu, Yiling Pharmaceutical, Tianjin Pharmaceutical Da Ren Tang Group, Xiangxue Pharmaceutical, Harbin Pharmaceutical Group, Fusen Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Dosage Form, by Sales Channel, by Product Attribute, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Antipyretic Chinese Traditional Medicine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Antipyretic Chinese Traditional Medicine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Dosage Form, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Sales Channel, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Antipyretic Chinese Traditional Medicine Market growing?

Ans: The Antipyretic Chinese Traditional Medicine Market witnessing a CAGR of 6.8% during the forecast period 2026-2032.

What is the Antipyretic Chinese Traditional Medicine Market size in 2032?

Ans: The Antipyretic Chinese Traditional Medicine Market size in 2032 will be US$ 5172 million.

Who are the main players in the Antipyretic Chinese Traditional Medicine Market report?

Ans: The main players in the Antipyretic Chinese Traditional Medicine Market are Langrun, Hubei Jumpcan Pharmaceutical, Chasesun Pharmaceutical, Yangtze River Pharmaceutical, Jiangsu Kanion Pharmaceutical, Guangdong Leiyunshang, Shineway Pharma, Qingfeng Pharmaceutical, Jiangxi Prozin Pharmaceutical, Zhenao Jinyinhua Pharmaceutical, Shandong Runzhong Pharmaceutical, Sinopharm Group, Baiyunshan Mingxing Pharmaceutical, Guangzhou Pharmaceuticals Corporation, Yunnan Baiyao, CR Pharmaceutical Commercial Group, JiLin FuKang Pharmaceutical, Zhejiang CONBA Pharmaceutical, SemBioSys Genetics, Wecome Pharmaceutica, Guizhou Bailing Group Pharmaceutica, Xiuzheng Pharmaceutical, Taiji, China Beijing Tong Ren Tang Group Co. Ltd., Kunming Pharma, CR Sanjiu, Yiling Pharmaceutical, Tianjin Pharmaceutical Da Ren Tang Group, Xiangxue Pharmaceutical, Harbin Pharmaceutical Group, Fusen Pharmaceutical

1 Antipyretic Chinese Traditional Medicine Market Overview
1.1 Product Definition
1.2 Antipyretic Chinese Traditional Medicine by Dosage Form
1.2.1 Global Antipyretic Chinese Traditional Medicine Market Value by Dosage Form: 2025 vs 2032
1.2.2 Granule
1.2.3 Capsule
1.2.4 Tablet
1.2.5 Oral Liquid
1.2.6 Injection
1.3 Antipyretic Chinese Traditional Medicine by Product Attribute
1.3.1 Global Antipyretic Chinese Traditional Medicine Market Value by Product Attribute: 2025 vs 2032
1.3.2 OTC Patent Medicine
1.3.3 Prescription Patent Medicine
1.4 Antipyretic Chinese Traditional Medicine by Therapeutic Function
1.4.1 Global Antipyretic Chinese Traditional Medicine Market Value by Therapeutic Function: 2025 vs 2032
1.4.2 Heat-Clearing and Detoxifying
1.4.3 Wind-Heat Releasing
1.4.4 Exterior-Releasing and Antipyretic
1.4.5 Damp-Heat Clearing
1.4.6 Qi and Yin Supporting With Heat Relief
1.5 Antipyretic Chinese Traditional Medicine by Sales Channel
1.5.1 Global Antipyretic Chinese Traditional Medicine Market Value by Sales Channel: 2025 vs 2032
1.5.2 Online Sales
1.5.3 Offline Sales
1.6 Global Antipyretic Chinese Traditional Medicine Market Size Estimates and Forecasts
1.6.1 Global Antipyretic Chinese Traditional Medicine Revenue 2021–2032
1.6.2 Global Antipyretic Chinese Traditional Medicine Sales 2021–2032
1.6.3 Global Antipyretic Chinese Traditional Medicine Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Antipyretic Chinese Traditional Medicine Market Competition by Manufacturers
2.1 Global Antipyretic Chinese Traditional Medicine Sales Market Share by Manufacturers (2021–2026)
2.2 Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Antipyretic Chinese Traditional Medicine Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Antipyretic Chinese Traditional Medicine, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Antipyretic Chinese Traditional Medicine, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Antipyretic Chinese Traditional Medicine, Product Types and Applications
2.7 Global Key Manufacturers of Antipyretic Chinese Traditional Medicine, Date of Entry into the Industry
2.8 Global Antipyretic Chinese Traditional Medicine Market Competitive Situation and Trends
2.8.1 Global Antipyretic Chinese Traditional Medicine Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Antipyretic Chinese Traditional Medicine Players Market Share by Revenue
2.8.3 Global Antipyretic Chinese Traditional Medicine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Antipyretic Chinese Traditional Medicine Market Scenario by Region
3.1 Global Antipyretic Chinese Traditional Medicine Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Antipyretic Chinese Traditional Medicine Sales by Region: 2021–2032
3.2.1 Global Antipyretic Chinese Traditional Medicine Sales by Region: 2021–2026
3.2.2 Global Antipyretic Chinese Traditional Medicine Sales by Region: 2027–2032
3.3 Global Antipyretic Chinese Traditional Medicine Revenue by Region: 2021–2032
3.3.1 Global Antipyretic Chinese Traditional Medicine Revenue by Region: 2021–2026
3.3.2 Global Antipyretic Chinese Traditional Medicine Revenue by Region: 2027–2032
3.4 North America Antipyretic Chinese Traditional Medicine Market Facts & Figures by Country
3.4.1 North America Antipyretic Chinese Traditional Medicine Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Antipyretic Chinese Traditional Medicine Sales by Country (2021–2032)
3.4.3 North America Antipyretic Chinese Traditional Medicine Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Antipyretic Chinese Traditional Medicine Market Facts & Figures by Country
3.5.1 Europe Antipyretic Chinese Traditional Medicine Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Antipyretic Chinese Traditional Medicine Sales by Country (2021–2032)
3.5.3 Europe Antipyretic Chinese Traditional Medicine Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antipyretic Chinese Traditional Medicine Market Facts & Figures by Region
3.6.1 Asia Pacific Antipyretic Chinese Traditional Medicine Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Antipyretic Chinese Traditional Medicine Sales by Region (2021–2032)
3.6.3 Asia Pacific Antipyretic Chinese Traditional Medicine Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Antipyretic Chinese Traditional Medicine Market Facts & Figures by Country
3.7.1 Latin America Antipyretic Chinese Traditional Medicine Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Antipyretic Chinese Traditional Medicine Sales by Country (2021–2032)
3.7.3 Latin America Antipyretic Chinese Traditional Medicine Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antipyretic Chinese Traditional Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Antipyretic Chinese Traditional Medicine Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Antipyretic Chinese Traditional Medicine Sales by Country (2021–2032)
3.8.3 Middle East and Africa Antipyretic Chinese Traditional Medicine Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Dosage Form
4.1 Global Antipyretic Chinese Traditional Medicine Sales by Dosage Form (2021–2032)
4.1.1 Global Antipyretic Chinese Traditional Medicine Sales by Dosage Form (2021–2026)
4.1.2 Global Antipyretic Chinese Traditional Medicine Sales by Dosage Form (2027–2032)
4.1.3 Global Antipyretic Chinese Traditional Medicine Sales Market Share by Dosage Form (2021–2032)
4.2 Global Antipyretic Chinese Traditional Medicine Revenue by Dosage Form (2021–2032)
4.2.1 Global Antipyretic Chinese Traditional Medicine Revenue by Dosage Form (2021–2026)
4.2.2 Global Antipyretic Chinese Traditional Medicine Revenue by Dosage Form (2027–2032)
4.2.3 Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Dosage Form (2021–2032)
4.3 Global Antipyretic Chinese Traditional Medicine Price by Dosage Form (2021–2032)
5 Segment by Sales Channel
5.1 Global Antipyretic Chinese Traditional Medicine Sales by Sales Channel (2021–2032)
5.1.1 Global Antipyretic Chinese Traditional Medicine Sales by Sales Channel (2021–2026)
5.1.2 Global Antipyretic Chinese Traditional Medicine Sales by Sales Channel (2027–2032)
5.1.3 Global Antipyretic Chinese Traditional Medicine Sales Market Share by Sales Channel (2021–2032)
5.2 Global Antipyretic Chinese Traditional Medicine Revenue by Sales Channel (2021–2032)
5.2.1 Global Antipyretic Chinese Traditional Medicine Revenue by Sales Channel (2021–2026)
5.2.2 Global Antipyretic Chinese Traditional Medicine Revenue by Sales Channel (2027–2032)
5.2.3 Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Sales Channel (2021–2032)
5.3 Global Antipyretic Chinese Traditional Medicine Price by Sales Channel (2021–2032)
6 Key Companies Profiled
6.1 Langrun
6.1.1 Langrun Company Information
6.1.2 Langrun Description and Business Overview
6.1.3 Langrun Antipyretic Chinese Traditional Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Langrun Antipyretic Chinese Traditional Medicine Product Portfolio
6.1.5 Langrun Recent Developments/Updates
6.2 Hubei Jumpcan Pharmaceutical
6.2.1 Hubei Jumpcan Pharmaceutical Company Information
6.2.2 Hubei Jumpcan Pharmaceutical Description and Business Overview
6.2.3 Hubei Jumpcan Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Hubei Jumpcan Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolio
6.2.5 Hubei Jumpcan Pharmaceutical Recent Developments/Updates
6.3 Chasesun Pharmaceutical
6.3.1 Chasesun Pharmaceutical Company Information
6.3.2 Chasesun Pharmaceutical Description and Business Overview
6.3.3 Chasesun Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Chasesun Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolio
6.3.5 Chasesun Pharmaceutical Recent Developments/Updates
6.4 Yangtze River Pharmaceutical
6.4.1 Yangtze River Pharmaceutical Company Information
6.4.2 Yangtze River Pharmaceutical Description and Business Overview
6.4.3 Yangtze River Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Yangtze River Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolio
6.4.5 Yangtze River Pharmaceutical Recent Developments/Updates
6.5 Jiangsu Kanion Pharmaceutical
6.5.1 Jiangsu Kanion Pharmaceutical Company Information
6.5.2 Jiangsu Kanion Pharmaceutical Description and Business Overview
6.5.3 Jiangsu Kanion Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Jiangsu Kanion Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolio
6.5.5 Jiangsu Kanion Pharmaceutical Recent Developments/Updates
6.6 Guangdong Leiyunshang
6.6.1 Guangdong Leiyunshang Company Information
6.6.2 Guangdong Leiyunshang Description and Business Overview
6.6.3 Guangdong Leiyunshang Antipyretic Chinese Traditional Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Guangdong Leiyunshang Antipyretic Chinese Traditional Medicine Product Portfolio
6.6.5 Guangdong Leiyunshang Recent Developments/Updates
6.7 Shineway Pharma
6.7.1 Shineway Pharma Company Information
6.7.2 Shineway Pharma Description and Business Overview
6.7.3 Shineway Pharma Antipyretic Chinese Traditional Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Shineway Pharma Antipyretic Chinese Traditional Medicine Product Portfolio
6.7.5 Shineway Pharma Recent Developments/Updates
6.8 Qingfeng Pharmaceutical
6.8.1 Qingfeng Pharmaceutical Company Information
6.8.2 Qingfeng Pharmaceutical Description and Business Overview
6.8.3 Qingfeng Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Qingfeng Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolio
6.8.5 Qingfeng Pharmaceutical Recent Developments/Updates
6.9 Jiangxi Prozin Pharmaceutical
6.9.1 Jiangxi Prozin Pharmaceutical Company Information
6.9.2 Jiangxi Prozin Pharmaceutical Description and Business Overview
6.9.3 Jiangxi Prozin Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Jiangxi Prozin Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolio
6.9.5 Jiangxi Prozin Pharmaceutical Recent Developments/Updates
6.10 Zhenao Jinyinhua Pharmaceutical
6.10.1 Zhenao Jinyinhua Pharmaceutical Company Information
6.10.2 Zhenao Jinyinhua Pharmaceutical Description and Business Overview
6.10.3 Zhenao Jinyinhua Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Zhenao Jinyinhua Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolio
6.10.5 Zhenao Jinyinhua Pharmaceutical Recent Developments/Updates
6.11 Shandong Runzhong Pharmaceutical
6.11.1 Shandong Runzhong Pharmaceutical Company Information
6.11.2 Shandong Runzhong Pharmaceutical Description and Business Overview
6.11.3 Shandong Runzhong Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Shandong Runzhong Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolio
6.11.5 Shandong Runzhong Pharmaceutical Recent Developments/Updates
6.12 Sinopharm Group
6.12.1 Sinopharm Group Company Information
6.12.2 Sinopharm Group Description and Business Overview
6.12.3 Sinopharm Group Antipyretic Chinese Traditional Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Sinopharm Group Antipyretic Chinese Traditional Medicine Product Portfolio
6.12.5 Sinopharm Group Recent Developments/Updates
6.13 Baiyunshan Mingxing Pharmaceutical
6.13.1 Baiyunshan Mingxing Pharmaceutical Company Information
6.13.2 Baiyunshan Mingxing Pharmaceutical Description and Business Overview
6.13.3 Baiyunshan Mingxing Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Baiyunshan Mingxing Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolio
6.13.5 Baiyunshan Mingxing Pharmaceutical Recent Developments/Updates
6.14 Guangzhou Pharmaceuticals Corporation
6.14.1 Guangzhou Pharmaceuticals Corporation Company Information
6.14.2 Guangzhou Pharmaceuticals Corporation Description and Business Overview
6.14.3 Guangzhou Pharmaceuticals Corporation Antipyretic Chinese Traditional Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Guangzhou Pharmaceuticals Corporation Antipyretic Chinese Traditional Medicine Product Portfolio
6.14.5 Guangzhou Pharmaceuticals Corporation Recent Developments/Updates
6.15 Yunnan Baiyao
6.15.1 Yunnan Baiyao Company Information
6.15.2 Yunnan Baiyao Description and Business Overview
6.15.3 Yunnan Baiyao Antipyretic Chinese Traditional Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Yunnan Baiyao Antipyretic Chinese Traditional Medicine Product Portfolio
6.15.5 Yunnan Baiyao Recent Developments/Updates
6.16 CR Pharmaceutical Commercial Group
6.16.1 CR Pharmaceutical Commercial Group Company Information
6.16.2 CR Pharmaceutical Commercial Group Description and Business Overview
6.16.3 CR Pharmaceutical Commercial Group Antipyretic Chinese Traditional Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 CR Pharmaceutical Commercial Group Antipyretic Chinese Traditional Medicine Product Portfolio
6.16.5 CR Pharmaceutical Commercial Group Recent Developments/Updates
6.17 JiLin FuKang Pharmaceutical
6.17.1 JiLin FuKang Pharmaceutical Company Information
6.17.2 JiLin FuKang Pharmaceutical Description and Business Overview
6.17.3 JiLin FuKang Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 JiLin FuKang Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolio
6.17.5 JiLin FuKang Pharmaceutical Recent Developments/Updates
6.18 Zhejiang CONBA Pharmaceutical
6.18.1 Zhejiang CONBA Pharmaceutical Company Information
6.18.2 Zhejiang CONBA Pharmaceutical Description and Business Overview
6.18.3 Zhejiang CONBA Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Zhejiang CONBA Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolio
6.18.5 Zhejiang CONBA Pharmaceutical Recent Developments/Updates
6.19 SemBioSys Genetics
6.19.1 SemBioSys Genetics Company Information
6.19.2 SemBioSys Genetics Description and Business Overview
6.19.3 SemBioSys Genetics Antipyretic Chinese Traditional Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 SemBioSys Genetics Antipyretic Chinese Traditional Medicine Product Portfolio
6.19.5 SemBioSys Genetics Recent Developments/Updates
6.20 Wecome Pharmaceutica
6.20.1 Wecome Pharmaceutica Company Information
6.20.2 Wecome Pharmaceutica Description and Business Overview
6.20.3 Wecome Pharmaceutica Antipyretic Chinese Traditional Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Wecome Pharmaceutica Antipyretic Chinese Traditional Medicine Product Portfolio
6.20.5 Wecome Pharmaceutica Recent Developments/Updates
6.21 Guizhou Bailing Group Pharmaceutica
6.21.1 Guizhou Bailing Group Pharmaceutica Company Information
6.21.2 Guizhou Bailing Group Pharmaceutica Description and Business Overview
6.21.3 Guizhou Bailing Group Pharmaceutica Antipyretic Chinese Traditional Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 Guizhou Bailing Group Pharmaceutica Antipyretic Chinese Traditional Medicine Product Portfolio
6.21.5 Guizhou Bailing Group Pharmaceutica Recent Developments/Updates
6.22 Xiuzheng Pharmaceutical
6.22.1 Xiuzheng Pharmaceutical Company Information
6.22.2 Xiuzheng Pharmaceutical Description and Business Overview
6.22.3 Xiuzheng Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.22.4 Xiuzheng Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolio
6.22.5 Xiuzheng Pharmaceutical Recent Developments/Updates
6.23 Taiji
6.23.1 Taiji Company Information
6.23.2 Taiji Description and Business Overview
6.23.3 Taiji Antipyretic Chinese Traditional Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.23.4 Taiji Antipyretic Chinese Traditional Medicine Product Portfolio
6.23.5 Taiji Recent Developments/Updates
6.24 China Beijing Tong Ren Tang Group Co. Ltd.
6.24.1 China Beijing Tong Ren Tang Group Co. Ltd. Company Information
6.24.2 China Beijing Tong Ren Tang Group Co. Ltd. Description and Business Overview
6.24.3 China Beijing Tong Ren Tang Group Co. Ltd. Antipyretic Chinese Traditional Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.24.4 China Beijing Tong Ren Tang Group Co. Ltd. Antipyretic Chinese Traditional Medicine Product Portfolio
6.24.5 China Beijing Tong Ren Tang Group Co. Ltd. Recent Developments/Updates
6.25 Kunming Pharma
6.25.1 Kunming Pharma Company Information
6.25.2 Kunming Pharma Description and Business Overview
6.25.3 Kunming Pharma Antipyretic Chinese Traditional Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.25.4 Kunming Pharma Antipyretic Chinese Traditional Medicine Product Portfolio
6.25.5 Kunming Pharma Recent Developments/Updates
6.26 CR Sanjiu
6.26.1 CR Sanjiu Company Information
6.26.2 CR Sanjiu Description and Business Overview
6.26.3 CR Sanjiu Antipyretic Chinese Traditional Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.26.4 CR Sanjiu Antipyretic Chinese Traditional Medicine Product Portfolio
6.26.5 CR Sanjiu Recent Developments/Updates
6.27 Yiling Pharmaceutical
6.27.1 Yiling Pharmaceutical Company Information
6.27.2 Yiling Pharmaceutical Description and Business Overview
6.27.3 Yiling Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.27.4 Yiling Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolio
6.27.5 Yiling Pharmaceutical Recent Developments/Updates
6.28 Tianjin Pharmaceutical Da Ren Tang Group
6.28.1 Tianjin Pharmaceutical Da Ren Tang Group Company Information
6.28.2 Tianjin Pharmaceutical Da Ren Tang Group Description and Business Overview
6.28.3 Tianjin Pharmaceutical Da Ren Tang Group Antipyretic Chinese Traditional Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.28.4 Tianjin Pharmaceutical Da Ren Tang Group Antipyretic Chinese Traditional Medicine Product Portfolio
6.28.5 Tianjin Pharmaceutical Da Ren Tang Group Recent Developments/Updates
6.29 Xiangxue Pharmaceutical
6.29.1 Xiangxue Pharmaceutical Company Information
6.29.2 Xiangxue Pharmaceutical Description and Business Overview
6.29.3 Xiangxue Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.29.4 Xiangxue Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolio
6.29.5 Xiangxue Pharmaceutical Recent Developments/Updates
6.30 Harbin Pharmaceutical Group
6.30.1 Harbin Pharmaceutical Group Company Information
6.30.2 Harbin Pharmaceutical Group Description and Business Overview
6.30.3 Harbin Pharmaceutical Group Antipyretic Chinese Traditional Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.30.4 Harbin Pharmaceutical Group Antipyretic Chinese Traditional Medicine Product Portfolio
6.30.5 Harbin Pharmaceutical Group Recent Developments/Updates
6.31 Fusen Pharmaceutical
6.31.1 Fusen Pharmaceutical Company Information
6.31.2 Fusen Pharmaceutical Description and Business Overview
6.31.3 Fusen Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.31.4 Fusen Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolio
6.31.5 Fusen Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antipyretic Chinese Traditional Medicine Industry Chain Analysis
7.2 Antipyretic Chinese Traditional Medicine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antipyretic Chinese Traditional Medicine Production Mode & Process Analysis
7.4 Antipyretic Chinese Traditional Medicine Sales and Marketing
7.4.1 Antipyretic Chinese Traditional Medicine Sales Channels
7.4.2 Antipyretic Chinese Traditional Medicine Distributors
7.5 Antipyretic Chinese Traditional Medicine Customer Analysis
8 Antipyretic Chinese Traditional Medicine Market Dynamics
8.1 Antipyretic Chinese Traditional Medicine Industry Trends
8.2 Antipyretic Chinese Traditional Medicine Market Drivers
8.3 Antipyretic Chinese Traditional Medicine Market Challenges
8.4 Antipyretic Chinese Traditional Medicine Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Antipyretic Chinese Traditional Medicine Market Value by Dosage Form (US$ Million), 2025 vs 2032
 Table 2. Global Antipyretic Chinese Traditional Medicine Market Value by Product Attribute (US$ Million), 2025 vs 2032
 Table 3. Global Antipyretic Chinese Traditional Medicine Market Value by Therapeutic Function (US$ Million), 2025 vs 2032
 Table 4. Global Antipyretic Chinese Traditional Medicine Market Value by Sales Channel (US$ Million), 2025 vs 2032
 Table 5. Global Antipyretic Chinese Traditional Medicine Market Competitive Situation by Manufacturers in 2025
 Table 6. Global Antipyretic Chinese Traditional Medicine Sales (M Units) of Key Manufacturers (2021–2026)
 Table 7. Global Antipyretic Chinese Traditional Medicine Sales Market Share by Manufacturers (2021–2026)
 Table 8. Global Antipyretic Chinese Traditional Medicine Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 9. Global Antipyretic Chinese Traditional Medicine Revenue Share by Manufacturers (2021–2026)
 Table 10. Global Market Antipyretic Chinese Traditional Medicine Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 11. Global Key Players of Antipyretic Chinese Traditional Medicine, Industry Ranking, 2023 vs 2024 vs 2025
 Table 12. Global Key Manufacturers of Antipyretic Chinese Traditional Medicine, Manufacturing Sites and Headquarters
 Table 13. Global Key Manufacturers of Antipyretic Chinese Traditional Medicine, Product Types and Applications
 Table 14. Global Key Manufacturers of Antipyretic Chinese Traditional Medicine, Date of Entry into the Industry
 Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 16. Global Antipyretic Chinese Traditional Medicine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Antipyretic Chinese Traditional Medicine Revenue, 2025
 Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 18. Global Antipyretic Chinese Traditional Medicine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 19. Global Antipyretic Chinese Traditional Medicine Sales by Region (M Units), 2021–2026
 Table 20. Global Antipyretic Chinese Traditional Medicine Sales Market Share by Region (2021–2026)
 Table 21. Global Antipyretic Chinese Traditional Medicine Sales by Region (M Units), 2027–2032
 Table 22. Global Antipyretic Chinese Traditional Medicine Sales Market Share by Region (2027–2032)
 Table 23. Global Antipyretic Chinese Traditional Medicine Revenue by Region (US$ Million), 2021–2026
 Table 24. Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Region (2021–2026)
 Table 25. Global Antipyretic Chinese Traditional Medicine Revenue by Region (US$ Million), 2027–2032
 Table 26. Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Region (2027–2032)
 Table 27. North America Antipyretic Chinese Traditional Medicine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 28. North America Antipyretic Chinese Traditional Medicine Sales by Country (M Units), 2021–2026
 Table 29. North America Antipyretic Chinese Traditional Medicine Sales by Country (M Units), 2027–2032
 Table 30. North America Antipyretic Chinese Traditional Medicine Revenue by Country (US$ Million), 2021–2026
 Table 31. North America Antipyretic Chinese Traditional Medicine Revenue by Country (US$ Million), 2027–2032
 Table 32. Europe Antipyretic Chinese Traditional Medicine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 33. Europe Antipyretic Chinese Traditional Medicine Sales by Country (M Units), 2021–2026
 Table 34. Europe Antipyretic Chinese Traditional Medicine Sales by Country (M Units), 2027–2032
 Table 35. Europe Antipyretic Chinese Traditional Medicine Revenue by Country (US$ Million), 2021–2026
 Table 36. Europe Antipyretic Chinese Traditional Medicine Revenue by Country (US$ Million), 2027–2032
 Table 37. Asia Pacific Antipyretic Chinese Traditional Medicine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 38. Asia Pacific Antipyretic Chinese Traditional Medicine Sales by Region (M Units), 2021–2026
 Table 39. Asia Pacific Antipyretic Chinese Traditional Medicine Sales by Region (M Units), 2027–2032
 Table 40. Asia Pacific Antipyretic Chinese Traditional Medicine Revenue by Region (US$ Million), 2021–2026
 Table 41. Asia Pacific Antipyretic Chinese Traditional Medicine Revenue by Region (US$ Million), 2027–2032
 Table 42. Latin America Antipyretic Chinese Traditional Medicine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 43. Latin America Antipyretic Chinese Traditional Medicine Sales by Country (M Units), 2021–2026
 Table 44. Latin America Antipyretic Chinese Traditional Medicine Sales by Country (M Units), 2027–2032
 Table 45. Latin America Antipyretic Chinese Traditional Medicine Revenue by Country (US$ Million), 2021–2026
 Table 46. Latin America Antipyretic Chinese Traditional Medicine Revenue by Country (US$ Million), 2027–2032
 Table 47. Middle East and Africa Antipyretic Chinese Traditional Medicine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 48. Middle East and Africa Antipyretic Chinese Traditional Medicine Sales by Country (M Units), 2021–2026
 Table 49. Middle East and Africa Antipyretic Chinese Traditional Medicine Sales by Country (M Units), 2027–2032
 Table 50. Middle East and Africa Antipyretic Chinese Traditional Medicine Revenue by Country (US$ Million), 2021–2026
 Table 51. Middle East and Africa Antipyretic Chinese Traditional Medicine Revenue by Country (US$ Million), 2027–2032
 Table 52. Global Antipyretic Chinese Traditional Medicine Sales (M Units) by Dosage Form (2021–2026)
 Table 53. Global Antipyretic Chinese Traditional Medicine Sales (M Units) by Dosage Form (2027–2032)
 Table 54. Global Antipyretic Chinese Traditional Medicine Sales Market Share by Dosage Form (2021–2026)
 Table 55. Global Antipyretic Chinese Traditional Medicine Sales Market Share by Dosage Form (2027–2032)
 Table 56. Global Antipyretic Chinese Traditional Medicine Revenue (US$ Million) by Dosage Form (2021–2026)
 Table 57. Global Antipyretic Chinese Traditional Medicine Revenue (US$ Million) by Dosage Form (2027–2032)
 Table 58. Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Dosage Form (2021–2026)
 Table 59. Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Dosage Form (2027–2032)
 Table 60. Global Antipyretic Chinese Traditional Medicine Price (US$/Unit) by Dosage Form (2021–2026)
 Table 61. Global Antipyretic Chinese Traditional Medicine Price (US$/Unit) by Dosage Form (2027–2032)
 Table 62. Global Antipyretic Chinese Traditional Medicine Sales (M Units) by Sales Channel (2021–2026)
 Table 63. Global Antipyretic Chinese Traditional Medicine Sales (M Units) by Sales Channel (2027–2032)
 Table 64. Global Antipyretic Chinese Traditional Medicine Sales Market Share by Sales Channel (2021–2026)
 Table 65. Global Antipyretic Chinese Traditional Medicine Sales Market Share by Sales Channel (2027–2032)
 Table 66. Global Antipyretic Chinese Traditional Medicine Revenue (US$ Million) by Sales Channel (2021–2026)
 Table 67. Global Antipyretic Chinese Traditional Medicine Revenue (US$ Million) by Sales Channel (2027–2032)
 Table 68. Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Sales Channel (2021–2026)
 Table 69. Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Sales Channel (2027–2032)
 Table 70. Global Antipyretic Chinese Traditional Medicine Price (US$/Unit) by Sales Channel (2021–2026)
 Table 71. Global Antipyretic Chinese Traditional Medicine Price (US$/Unit) by Sales Channel (2027–2032)
 Table 72. Langrun Company Information
 Table 73. Langrun Description and Business Overview
 Table 74. Langrun Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 75. Langrun Antipyretic Chinese Traditional Medicine Product
 Table 76. Langrun Recent Developments/Updates
 Table 77. Hubei Jumpcan Pharmaceutical Company Information
 Table 78. Hubei Jumpcan Pharmaceutical Description and Business Overview
 Table 79. Hubei Jumpcan Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 80. Hubei Jumpcan Pharmaceutical Antipyretic Chinese Traditional Medicine Product
 Table 81. Hubei Jumpcan Pharmaceutical Recent Developments/Updates
 Table 82. Chasesun Pharmaceutical Company Information
 Table 83. Chasesun Pharmaceutical Description and Business Overview
 Table 84. Chasesun Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 85. Chasesun Pharmaceutical Antipyretic Chinese Traditional Medicine Product
 Table 86. Chasesun Pharmaceutical Recent Developments/Updates
 Table 87. Yangtze River Pharmaceutical Company Information
 Table 88. Yangtze River Pharmaceutical Description and Business Overview
 Table 89. Yangtze River Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 90. Yangtze River Pharmaceutical Antipyretic Chinese Traditional Medicine Product
 Table 91. Yangtze River Pharmaceutical Recent Developments/Updates
 Table 92. Jiangsu Kanion Pharmaceutical Company Information
 Table 93. Jiangsu Kanion Pharmaceutical Description and Business Overview
 Table 94. Jiangsu Kanion Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 95. Jiangsu Kanion Pharmaceutical Antipyretic Chinese Traditional Medicine Product
 Table 96. Jiangsu Kanion Pharmaceutical Recent Developments/Updates
 Table 97. Guangdong Leiyunshang Company Information
 Table 98. Guangdong Leiyunshang Description and Business Overview
 Table 99. Guangdong Leiyunshang Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 100. Guangdong Leiyunshang Antipyretic Chinese Traditional Medicine Product
 Table 101. Guangdong Leiyunshang Recent Developments/Updates
 Table 102. Shineway Pharma Company Information
 Table 103. Shineway Pharma Description and Business Overview
 Table 104. Shineway Pharma Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 105. Shineway Pharma Antipyretic Chinese Traditional Medicine Product
 Table 106. Shineway Pharma Recent Developments/Updates
 Table 107. Qingfeng Pharmaceutical Company Information
 Table 108. Qingfeng Pharmaceutical Description and Business Overview
 Table 109. Qingfeng Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 110. Qingfeng Pharmaceutical Antipyretic Chinese Traditional Medicine Product
 Table 111. Qingfeng Pharmaceutical Recent Developments/Updates
 Table 112. Jiangxi Prozin Pharmaceutical Company Information
 Table 113. Jiangxi Prozin Pharmaceutical Description and Business Overview
 Table 114. Jiangxi Prozin Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 115. Jiangxi Prozin Pharmaceutical Antipyretic Chinese Traditional Medicine Product
 Table 116. Jiangxi Prozin Pharmaceutical Recent Developments/Updates
 Table 117. Zhenao Jinyinhua Pharmaceutical Company Information
 Table 118. Zhenao Jinyinhua Pharmaceutical Description and Business Overview
 Table 119. Zhenao Jinyinhua Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 120. Zhenao Jinyinhua Pharmaceutical Antipyretic Chinese Traditional Medicine Product
 Table 121. Zhenao Jinyinhua Pharmaceutical Recent Developments/Updates
 Table 122. Shandong Runzhong Pharmaceutical Company Information
 Table 123. Shandong Runzhong Pharmaceutical Description and Business Overview
 Table 124. Shandong Runzhong Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 125. Shandong Runzhong Pharmaceutical Antipyretic Chinese Traditional Medicine Product
 Table 126. Shandong Runzhong Pharmaceutical Recent Developments/Updates
 Table 127. Sinopharm Group Company Information
 Table 128. Sinopharm Group Description and Business Overview
 Table 129. Sinopharm Group Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 130. Sinopharm Group Antipyretic Chinese Traditional Medicine Product
 Table 131. Sinopharm Group Recent Developments/Updates
 Table 132. Baiyunshan Mingxing Pharmaceutical Company Information
 Table 133. Baiyunshan Mingxing Pharmaceutical Description and Business Overview
 Table 134. Baiyunshan Mingxing Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 135. Baiyunshan Mingxing Pharmaceutical Antipyretic Chinese Traditional Medicine Product
 Table 136. Baiyunshan Mingxing Pharmaceutical Recent Developments/Updates
 Table 137. Guangzhou Pharmaceuticals Corporation Company Information
 Table 138. Guangzhou Pharmaceuticals Corporation Description and Business Overview
 Table 139. Guangzhou Pharmaceuticals Corporation Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 140. Guangzhou Pharmaceuticals Corporation Antipyretic Chinese Traditional Medicine Product
 Table 141. Guangzhou Pharmaceuticals Corporation Recent Developments/Updates
 Table 142. Yunnan Baiyao Company Information
 Table 143. Yunnan Baiyao Description and Business Overview
 Table 144. Yunnan Baiyao Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 145. Yunnan Baiyao Antipyretic Chinese Traditional Medicine Product
 Table 146. Yunnan Baiyao Recent Developments/Updates
 Table 147. CR Pharmaceutical Commercial Group Company Information
 Table 148. CR Pharmaceutical Commercial Group Description and Business Overview
 Table 149. CR Pharmaceutical Commercial Group Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 150. CR Pharmaceutical Commercial Group Antipyretic Chinese Traditional Medicine Product
 Table 151. CR Pharmaceutical Commercial Group Recent Developments/Updates
 Table 152. JiLin FuKang Pharmaceutical Company Information
 Table 153. JiLin FuKang Pharmaceutical Description and Business Overview
 Table 154. JiLin FuKang Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 155. JiLin FuKang Pharmaceutical Antipyretic Chinese Traditional Medicine Product
 Table 156. JiLin FuKang Pharmaceutical Recent Developments/Updates
 Table 157. Zhejiang CONBA Pharmaceutical Company Information
 Table 158. Zhejiang CONBA Pharmaceutical Description and Business Overview
 Table 159. Zhejiang CONBA Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 160. Zhejiang CONBA Pharmaceutical Antipyretic Chinese Traditional Medicine Product
 Table 161. Zhejiang CONBA Pharmaceutical Recent Developments/Updates
 Table 162. SemBioSys Genetics Company Information
 Table 163. SemBioSys Genetics Description and Business Overview
 Table 164. SemBioSys Genetics Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 165. SemBioSys Genetics Antipyretic Chinese Traditional Medicine Product
 Table 166. SemBioSys Genetics Recent Developments/Updates
 Table 167. Wecome Pharmaceutica Company Information
 Table 168. Wecome Pharmaceutica Description and Business Overview
 Table 169. Wecome Pharmaceutica Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 170. Wecome Pharmaceutica Antipyretic Chinese Traditional Medicine Product
 Table 171. Wecome Pharmaceutica Recent Developments/Updates
 Table 172. Guizhou Bailing Group Pharmaceutica Company Information
 Table 173. Guizhou Bailing Group Pharmaceutica Description and Business Overview
 Table 174. Guizhou Bailing Group Pharmaceutica Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 175. Guizhou Bailing Group Pharmaceutica Antipyretic Chinese Traditional Medicine Product
 Table 176. Guizhou Bailing Group Pharmaceutica Recent Developments/Updates
 Table 177. Xiuzheng Pharmaceutical Company Information
 Table 178. Xiuzheng Pharmaceutical Description and Business Overview
 Table 179. Xiuzheng Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 180. Xiuzheng Pharmaceutical Antipyretic Chinese Traditional Medicine Product
 Table 181. Xiuzheng Pharmaceutical Recent Developments/Updates
 Table 182. Taiji Company Information
 Table 183. Taiji Description and Business Overview
 Table 184. Taiji Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 185. Taiji Antipyretic Chinese Traditional Medicine Product
 Table 186. Taiji Recent Developments/Updates
 Table 187. China Beijing Tong Ren Tang Group Co. Ltd. Company Information
 Table 188. China Beijing Tong Ren Tang Group Co. Ltd. Description and Business Overview
 Table 189. China Beijing Tong Ren Tang Group Co. Ltd. Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 190. China Beijing Tong Ren Tang Group Co. Ltd. Antipyretic Chinese Traditional Medicine Product
 Table 191. China Beijing Tong Ren Tang Group Co. Ltd. Recent Developments/Updates
 Table 192. Kunming Pharma Company Information
 Table 193. Kunming Pharma Description and Business Overview
 Table 194. Kunming Pharma Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 195. Kunming Pharma Antipyretic Chinese Traditional Medicine Product
 Table 196. Kunming Pharma Recent Developments/Updates
 Table 197. CR Sanjiu Company Information
 Table 198. CR Sanjiu Description and Business Overview
 Table 199. CR Sanjiu Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 200. CR Sanjiu Antipyretic Chinese Traditional Medicine Product
 Table 201. CR Sanjiu Recent Developments/Updates
 Table 202. Yiling Pharmaceutical Company Information
 Table 203. Yiling Pharmaceutical Description and Business Overview
 Table 204. Yiling Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 205. Yiling Pharmaceutical Antipyretic Chinese Traditional Medicine Product
 Table 206. Yiling Pharmaceutical Recent Developments/Updates
 Table 207. Tianjin Pharmaceutical Da Ren Tang Group Company Information
 Table 208. Tianjin Pharmaceutical Da Ren Tang Group Description and Business Overview
 Table 209. Tianjin Pharmaceutical Da Ren Tang Group Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 210. Tianjin Pharmaceutical Da Ren Tang Group Antipyretic Chinese Traditional Medicine Product
 Table 211. Tianjin Pharmaceutical Da Ren Tang Group Recent Developments/Updates
 Table 212. Xiangxue Pharmaceutical Company Information
 Table 213. Xiangxue Pharmaceutical Description and Business Overview
 Table 214. Xiangxue Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 215. Xiangxue Pharmaceutical Antipyretic Chinese Traditional Medicine Product
 Table 216. Xiangxue Pharmaceutical Recent Developments/Updates
 Table 217. Harbin Pharmaceutical Group Company Information
 Table 218. Harbin Pharmaceutical Group Description and Business Overview
 Table 219. Harbin Pharmaceutical Group Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 220. Harbin Pharmaceutical Group Antipyretic Chinese Traditional Medicine Product
 Table 221. Harbin Pharmaceutical Group Recent Developments/Updates
 Table 222. Fusen Pharmaceutical Company Information
 Table 223. Fusen Pharmaceutical Description and Business Overview
 Table 224. Fusen Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 225. Fusen Pharmaceutical Antipyretic Chinese Traditional Medicine Product
 Table 226. Fusen Pharmaceutical Recent Developments/Updates
 Table 227. Key Raw Materials Lists
 Table 228. Raw Materials Key Suppliers Lists
 Table 229. Antipyretic Chinese Traditional Medicine Distributors List
 Table 230. Antipyretic Chinese Traditional Medicine Customers List
 Table 231. Antipyretic Chinese Traditional Medicine Market Trends
 Table 232. Antipyretic Chinese Traditional Medicine Market Drivers
 Table 233. Antipyretic Chinese Traditional Medicine Market Challenges
 Table 234. Antipyretic Chinese Traditional Medicine Market Restraints
 Table 235. Research Programs/Design for This Report
 Table 236. Key Data Information from Secondary Sources
 Table 237. Key Data Information from Primary Sources
 Table 238. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Antipyretic Chinese Traditional Medicine
 Figure 2. Global Antipyretic Chinese Traditional Medicine Market Value by Dosage Form (US$ Million), 2021–2032
 Figure 3. Global Antipyretic Chinese Traditional Medicine Market Share by Dosage Form: 2025 & 2032
 Figure 4. Granule Product Picture
 Figure 5. Capsule Product Picture
 Figure 6. Tablet Product Picture
 Figure 7. Oral Liquid Product Picture
 Figure 8. Injection Product Picture
 Figure 9. Global Antipyretic Chinese Traditional Medicine Market Value by Product Attribute (US$ Million), 2021–2032
 Figure 10. Global Antipyretic Chinese Traditional Medicine Market Share by Product Attribute: 2025 vs 2032
 Figure 11. OTC Patent Medicine Product Picture
 Figure 12. Prescription Patent Medicine Product Picture
 Figure 13. Global Antipyretic Chinese Traditional Medicine Market Value by Therapeutic Function (US$ Million), 2021–2032
 Figure 14. Global Antipyretic Chinese Traditional Medicine Market Share by Therapeutic Function: 2025 vs 2032
 Figure 15. Heat-Clearing and Detoxifying Product Picture
 Figure 16. Wind-Heat Releasing Product Picture
 Figure 17. Exterior-Releasing and Antipyretic Product Picture
 Figure 18. Damp-Heat Clearing Product Picture
 Figure 19. Qi and Yin Supporting With Heat Relief Product Picture
 Figure 20. Global Antipyretic Chinese Traditional Medicine Market Value by Sales Channel (US$ Million), 2021–2032
 Figure 21. Global Antipyretic Chinese Traditional Medicine Market Share by Sales Channel: 2025 & 2032
 Figure 22. Online Sales
 Figure 23. Offline Sales
 Figure 24. Global Antipyretic Chinese Traditional Medicine Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 25. Global Antipyretic Chinese Traditional Medicine Market Size (US$ Million), 2021–2032
 Figure 26. Global Antipyretic Chinese Traditional Medicine Sales (M Units), 2021–2032
 Figure 27. Global Antipyretic Chinese Traditional Medicine Average Price (US$/Unit), 2021–2032
 Figure 28. Antipyretic Chinese Traditional Medicine Report Years Considered
 Figure 29. Antipyretic Chinese Traditional Medicine Sales Share by Manufacturers in 2025
 Figure 30. Global Antipyretic Chinese Traditional Medicine Revenue Share by Manufacturers in 2025
 Figure 31. Top 5 and Top 10 Global Antipyretic Chinese Traditional Medicine Players: Market Share by Revenue in Antipyretic Chinese Traditional Medicine in 2025
 Figure 32. Antipyretic Chinese Traditional Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 33. Global Antipyretic Chinese Traditional Medicine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 34. North America Antipyretic Chinese Traditional Medicine Sales Market Share by Country (2021–2032)
 Figure 35. North America Antipyretic Chinese Traditional Medicine Revenue Market Share by Country (2021–2032)
 Figure 36. U.S. Antipyretic Chinese Traditional Medicine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Canada Antipyretic Chinese Traditional Medicine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Europe Antipyretic Chinese Traditional Medicine Sales Market Share by Country (2021–2032)
 Figure 39. Europe Antipyretic Chinese Traditional Medicine Revenue Market Share by Country (2021–2032)
 Figure 40. Germany Antipyretic Chinese Traditional Medicine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. France Antipyretic Chinese Traditional Medicine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. U.K. Antipyretic Chinese Traditional Medicine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Italy Antipyretic Chinese Traditional Medicine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Russia Antipyretic Chinese Traditional Medicine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Asia Pacific Antipyretic Chinese Traditional Medicine Sales Market Share by Region (2021–2032)
 Figure 46. Asia Pacific Antipyretic Chinese Traditional Medicine Revenue Market Share by Region (2021–2032)
 Figure 47. China Antipyretic Chinese Traditional Medicine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Japan Antipyretic Chinese Traditional Medicine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. South Korea Antipyretic Chinese Traditional Medicine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. India Antipyretic Chinese Traditional Medicine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Australia Antipyretic Chinese Traditional Medicine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Taiwan Antipyretic Chinese Traditional Medicine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Indonesia Antipyretic Chinese Traditional Medicine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Thailand Antipyretic Chinese Traditional Medicine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Malaysia Antipyretic Chinese Traditional Medicine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. Philippines Antipyretic Chinese Traditional Medicine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 57. Latin America Antipyretic Chinese Traditional Medicine Sales Market Share by Country (2021–2032)
 Figure 58. Latin America Antipyretic Chinese Traditional Medicine Revenue Market Share by Country (2021–2032)
 Figure 59. Mexico Antipyretic Chinese Traditional Medicine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 60. Brazil Antipyretic Chinese Traditional Medicine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 61. Argentina Antipyretic Chinese Traditional Medicine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 62. Middle East and Africa Antipyretic Chinese Traditional Medicine Sales Market Share by Country (2021–2032)
 Figure 63. Middle East and Africa Antipyretic Chinese Traditional Medicine Revenue Market Share by Country (2021–2032)
 Figure 64. Turkey Antipyretic Chinese Traditional Medicine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 65. Saudi Arabia Antipyretic Chinese Traditional Medicine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 66. UAE Antipyretic Chinese Traditional Medicine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 67. Global Sales Market Share of Antipyretic Chinese Traditional Medicine by Dosage Form (2021–2032)
 Figure 68. Global Revenue Market Share of Antipyretic Chinese Traditional Medicine by Dosage Form (2021–2032)
 Figure 69. Global Antipyretic Chinese Traditional Medicine Price (US$/Unit) by Dosage Form (2021–2032)
 Figure 70. Global Sales Market Share of Antipyretic Chinese Traditional Medicine by Sales Channel (2021–2032)
 Figure 71. Global Revenue Market Share of Antipyretic Chinese Traditional Medicine by Sales Channel (2021–2032)
 Figure 72. Global Antipyretic Chinese Traditional Medicine Price (US$/Unit) by Sales Channel (2021–2032)
 Figure 73. Antipyretic Chinese Traditional Medicine Value Chain
 Figure 74. Channels of Distribution (Direct Vs Distribution)
 Figure 75. Bottom-up and Top-down Approaches for This Report
 Figure 76. Data Triangulation
 Figure 77. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS